Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 409-420 of 4,306
Behavioral study icon
Not Yet RecruitingNCT07593456

NST-SPARK Phase 1 STTR (IGNITE)

This study is not yet recruiting in the United States. It focuses on Schizophrenia.

Multiple locations, including Glen Oaks
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
North Shore Therapeutics, Inc.
Condition
Schizophrenia
Other study type icon
Not Yet RecruitingNCT07387705

On Track for Wellness (OTW) Stepped Wedge Cluster study

This study is not yet recruiting. It focuses on Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Sponsor
University of Illinois at Chicago
Condition
Schizophrenia
Drug study icon
CompletedNCT00650611

Safety study of ziprasidone in Schizophrenia

This study is completed in the United States. It is testing ziprasidone for Schizophrenia.

Multiple locations, including San Diego
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugA study involving a medication or substance.From 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
TerminatedNCT03669640

Effects of RO6889450 (Ralmitaront) in people with Schizophrenia or Schizoaffective Disorder and Negative Symptoms

This study was terminated in the United States, in Japan, in Spain, .... It is testing Effects of RO6889450 (Ralmitaront) for schizophrenia.

Multiple locations, including Bellflower
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Japan, Spain, ...
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
WithdrawnNCT06878833

Safety study of Long-Acting Oral Risperidone in schizophrenia

This study was withdrawn. It is testing Long-Acting Oral Risperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Sponsor
Lyndra Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04512066

A study of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in people with an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

This study is completed in the United States, in Japan, in Russia, .... It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United States, Japan, Russia, ...
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
CompletedNCT00212784

Asenapine Using an Active Control for schizophrenia

This study is completed. It is testing asenapine Using an Active Control for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.